Product Cat. No.: GBS-007
For Research Use Only
Kappa chain probe detection kit.
10 Tests/box
This kit uses fluorescence in situ hybridization to detect kappa gene status in vitro. The detection samples are B-cell lymphoma surgical resection or biopsy tissue paraffin embedded samples. This kit is only applicable to the detection of kappa gene rearrangement status and provides doctors with auxiliary information for diagnosis.
The most common genetic abnormality in B-cell lymphoma is the heterotopic and rearrangement of immunoglobulin heavy chain (IGH) sites. In addition, 5-10% of B-cell lymphomas have heterotopic and rearrangement of immunoglobulin light chain. Immunoglobulin light chains include kappa chain (IGK) and lambda chain (IGL), and their positions on human chromosomes are 2p12 and 22q11, respectively.Current studies show that IGK rearrangement is acquired gene damage, and B-cell lymphoma cells are formed by the monoclonal proliferation of B cells with genetic abnormalities, so there are monoclonal changes. This monoclonal IGK gene rearrangement can be used as a specific molecular markerfor the detection of B-cell lymphoma forthe diagnosis of B-cell lymphoma, and this clonal detection is helpful to distinguish polyclonal reactive hyperplasia from malignant proliferative disease.
Therefore, the detection of IGK gene status has guiding significance for the treatment and prognosis of B-cell lymphoma.
This kit is based on fluorescence in situ hybridization technology. One nucleotide of the nucleic acid probe is labeled with fluorescein. The detected target gene and the nucleic acid probe are homologous and complementary. After denaturation, annealing and renaturation, the hybrid of the target gene and the nucleic acid probe can be formed. Through the fluorescence detection system, qualitative, quantitative or relative positioning analysis of the target gene under the microscope.
This kit usesrhodamine fluorescein (rho) – labeled orange probe and fluorescein isothiocyanate (FITC) – labeled green probe. The two probes can be combined to the target detection site by in situ hybridization. Under normal conditions (no rearrangement of kappa gene), these two probes hybridize and bind to the same gene, and are displayed as green and orange signals close to each other or yellow signals overlapping each other under fluorescence microscope. When there is a gene rearrangement, the green and red signals are “broken” due to the replacement of the recombination fusion partners, and appear as monochromatic signals separated far away. The rearrangement of kappa gene in the tissues of B-cell lymphoma patients was detected in vitro by this method of fracture fluorescence in situ hybridization, which provides a reference basis for the treatment, prognosis and medication of B-cell lymphoma patients.
This kit is composed of kappa break apart probe hybridization solution as shown in Table 1.
Component name | Specifications | Quantity | Main components |
---|---|---|---|
kappa break apart probe | 100μL/Tube | 1 | IGK Orange probe IGK Green probe |
Keep sealed away from light at -20oC±5oC. The product is valid for 20 months. Within 24 hours for short-term preservation, keep sealed at 2-8oC in dark. For long-term preservation after opening, keep the lid sealed at -20oC±5oC away from light. The kit is transported below 0oC.
Fluorescence microscopy imaging system including fluorescence microscopy and filter setssuitable for DAPI, Green, and Orange.
No. | Abnormal cell (%) |
---|---|
Sample 1 |
5 |
Sample 2 |
3 |
------------ |
.......... |
Sample 20 |
4 |
average |
3 |
SD |
0.3 |
threshold |
(Abnormal threshold = average (m) + 3 × SD)3.9 |
2. Result judgment:
If the detected value of the number of cells displaying the abnormal signal mode is greater than the abnormal threshold, it is determined as a positive result; If the detected value of the number of cells displaying the abnormal signal mode is less than the abnormal threshold, it is determined as a negative result; If the detection value of the number of cells in the abnormal signal mode is equal to the abnormal threshold, increase the number of cells in the observation sample and count 200 cells to judge the final result.
This kit is used for B-cell lymphoma surgical resection or biopsy tissue paraffin embedded specimens, and is not recommended for other tissues. The detection ability of paraffin tissue samplesthat have been stored for too long cannot be evaluated according to thisinstruction; It shall be operated according to the procedures provided in this manual. Changing the procedures may change the inspection results; This kit only detects kappa gene status and cannot be used as the only basis for treatment, prognosis judgment or other clinical management of B-cell lymphoma patients. It needs to be comprehensively evaluated on the basis of medical history and other diagnostic results.
V1. 0: Approval date: November 02, 2018.
V1. 1: Revision date: December 07, 2021.